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Maf1 is the ‘master’ repressor of RNA polymerase III
(Pol III) transcription in yeast, and is conserved in eukar-
yotes. Maf1 is a phospho-integrator, with unfavourable
growth conditions leading to rapid Maf1 dephosphorylation,
nuclear accumulation, binding to RNA Pol III at Pol III genes
and transcriptional repression. Here, we establish the
protein phosphatase 4 (PP4) complex as the main Maf1
phosphatase, and deﬁne the involved catalytic (Pph3), scaf-
fold (Psy2) and regulatory subunits (Rrd1, Tip41), as well as
uninvolved subunits (Psy4, Rrd2). Multiple approaches
support a central role for PP4 in Maf1 dephosphorylation,
Maf1 nuclear localization and the rapid repression of Pol III
in the nucleus. PP4 action is likely direct, as a portion of PP4
co-precipitates with Maf1, and puriﬁed PP4 dephosphory-
lates Maf1 in vitro. Furthermore, Pph3 mediates (either
largely or fully) rapid Maf1 dephosphorylation in response
to diverse stresses, suggesting PP4 plays a key role in the
integration of cell nutrition and stress conditions by Maf1 to
enable Pol III regulation.
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Introduction
The protein synthesis machinery (PSM) is derived from both
protein-coding and noncoding RNAs, and their synthesis is
regulated by multiple growth conditions. Transcription of the
PSM involves regulation of all three RNA polymerases:
ribosomal RNAs are mostly transcribed by polymerase I
(Pol I) (5S rRNA excepted, which is transcribed by Pol III),
ribosomal protein-coding mRNAs are transcribed by Pol II,
and tRNAs are transcribed by Pol III. Together, this PSM-
related transcription accounts for B80% of nuclear transcrip-
tion in proliferating cells (Moss and Stefanovsky, 2002).
Pol III transcribes short (o550bp) noncoding RNAs involved
in translation (e.g., tRNAs, SCR1), splicing (e.g., U6), and a
variety of other functions (Dieci et al, 2007). For tRNAs, the
most common Pol III gene class by far, important regulatory
elements include intragenic A- and B-box DNA consensus
elements, as well as a stretch of at least four thymidine
residues, which terminates transcription (Orioli et al, 2011).
Three subcomplexes constitute the basic Pol III machinery,
each performing essential functions. In simpliﬁed terms,
TFIIIC complex recognizes the A- and B-boxes and recruits
TFIIIB complex; TFIIIB is the initiation complex, containing
Brf1, Bdp1 and TBP, and together with TFIIIC recruits Pol III;
and Pol III produces the RNA (Schramm and Hernandez,
2002).
In response to various unfavourable growth conditions and
stress, repression of virtually all components of the PSM is
observed—and is conveyed to Pol III via multiple signalling
pathways, including those mediated by Target of Rapamycin
(TOR) (Willis et al, 2004; Wullschleger et al, 2006). Our work
here focusses on Pol III targets, which undergo rapid
(o30min) repression during nutrient deprivation (ND) and
other stress conditions, which is likely important for resource
conservation. Furthermore, many cancer types overexpress
Pol III target RNAs, due in part to regulation by certain
tumour suppressors/oncogenes (Felton-Edkins et al, 2003;
Gomez-Roman et al, 2003). While yeast do not possess the
tumour suppressor counterparts, all eukaryotes share a
conserved central regulator of Pol III, termed Maf1 (Pluta
et al, 2001).
As the Pol III repertoire is largely (though not solely)
dedicated to the PSM, Pol III regulation is less complex
than Pol II. Notably, and in contrast to the Pol II system,
Pol III promoters and the basal machinery in yeast largely
conform to a ‘default on’ state, and rely on a ‘master’ Pol III
repressor, Maf1, which is required for the attenuation of the
Pol III system in all tested unfavourable growth conditions:
ND, DNA damage, oxidative stress and cell wall stress
(Upadhya et al, 2002; Boisnard et al, 2009; Nguyen et al,
2010). Maf1 interacts in vivo (directly or indirectly) with the
Pol III components Rpc160, Rpc34 and Rpc82, as well as the
TFIIIB component Brf1 (Pluta et al, 2001; Desai et al, 2005;
Roberts et al, 2006). Best characterized is the direct interac-
tion of Maf1 with the N-terminus of Rpc160, shown ﬁrst
in vitro (Oﬁcjalska-Pham et al, 2006) and greatly enhanced by
the recent crystal structure of Maf1 and cryo-electron micro-
scopy structure of Maf1 bound to Pol III (Vannini et al, 2010).
Maf1 is not involved in the repression of ribosomal protein
genes or Pol I-encoded ribosomal RNAs, suggesting that Maf1
is speciﬁcally dedicated to repression of Pol III (Upadhya
et al, 2002). In summary, Maf1 functions as a master reg-
ulator/integrator that speciﬁcally represses Pol III transcrip-
tion in response to multiple stresses by direct interaction with
the Pol III machinery.
Mechanistically, yeast Maf1 is a phosphoprotein, and is
phosphorylated and mostly cytoplasmic during favourable
growth conditions (Roberts et al, 2006), allowing robust Pol
III transcription. Phosphorylation by Sch9 and protein kinase
A (PKA), and nuclear export by Msn5, are important for
maintaining its cytoplasmic localization in yeast (Moir et al,
2006; Towpik et al, 2008; Huber et al, 2009; Lee et al, 2009).
Maf1 phosphorylation by casein kinase 2 or TOR complex 1
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1440(TORC1) also antagonizes Maf1 repression of Pol III, in part
by inhibiting its association with Pol III at Pol III-transcribed
genes, a property necessary to execute repression in the
nucleus (Wei et al, 2009; Graczyk et al, 2011). Upon stress,
Maf1 is rapidly dephosphorylated, accumulates in the nu-
cleus, and becomes highly enriched at Pol III target genes, as
shown by whole-genome chromatin immunoprecipitation
(ChIP)-on-chip studies (Oﬁcjalska-Pham et al, 2006; Roberts
et al, 2006). Importantly, Maf1 dephosphorylation is a re-
quired step in Pol III repression conserved from yeast to
human (Reina et al, 2006; Goodfellow et al, 2008;
Kantidakis et al, 2010; Michels et al, 2010). Furthermore,
in vitro systems have demonstrated that Maf1 blocks recruit-
ment of TFIIIB to preformed TFIIIC–DNA complexes or
recruitment of Pol III to TFIIIB–TFIIIC–DNA complexes
(Desai et al, 2005). However, in vivo, Maf1 can repress Pol
III while all three subcomplexes remain on DNA (Pol III,
TFIIIB and TFIIIC). The data can be reconciled by postulating
two phases of repression: (1) the acute phase (within 30min
of stress/ND), during which Maf1 associates with Pol III on
DNA and represses transcription and (2) the prolonged
phase, during which TFIIIB and Pol III are displaced from
DNA, the recruitment of new active Pol III complexes is
inhibited, and repression is maintained. (Note: models
for kinase/phosphatase interplay are addressed in the
Discussion). As Pol III speciﬁcally interacts with the unpho-
sphorylated form of Maf1, Maf1 dephosphorylation likely
impacts the acute establishment phase of repression
(Roberts et al, 2006). Movement to the nucleus itself is
insufﬁcient to impose Pol III repression, as Pol III remains
fully active when the Maf1 exportin Msn5 is deleted, even
though msn5D mutants have constitutively nuclear Maf1
(Towpik et al, 2008). This strongly suggests that dephosphor-
ylation of Maf1 is needed in the nucleus to execute repres-
sion, not simply to antagonize nuclear export. Therefore, it is
important to be able to separate the effect of phosphorylation
on nuclear localization of Maf1 from that of execution of Pol
III repression. To this end, we have created a Maf1–Pol III
fusion, in attempt to bypass the regulation of nuclear locali-
zation and focus on the critical nuclear stage of repression
by Maf1.
Since Maf1 dephosphorylation is a common mechanism in
all reports of rapid Maf1-dependent repression of Pol III to
date, the precise identity of the phosphatase(s) and how
it/they are regulated is a central question. Indeed, the rapid
repression of Pol III via this mechanism is likely important for
conserving protein synthesis resources when unfavourable
conditions are encountered. In principle, Maf1 dephosphor-
ylation could be conducted by many phosphatases, or instead
by a ‘master’ phosphatase. Here, one report implicated the
PP2A phosphatase complex and a set of alternative PP2A
catalytic subunits in Maf1 dephosphorylation (Oﬁcjalska-
Pham et al, 2006). These phosphatases are all regulated by
TOR kinase, and rapamycin induces Maf1 dephosphorylation
and rapid inhibition of Pol III transcription (Zaragoza et al,
1998; Roberts et al, 2006). Pph21, Pph22 and Pph3 have
frequently been reported as alternative catalytic subunits of
PP2A. As previewed above, a triple catalytic mutant combi-
nation (pph21D, pph22-ts pph3D) is defective for Maf1 depho-
sphorylation and Pol III repression (Oﬁcjalska-Pham et al,
2006), but whether one or all of these proteins is involved
was not determined. However, other work questioned PP2A
involvement, as the PP2A scaffold mutant (tpd3D) displayed
clear Maf1 dephosphorylation (Roberts et al, 2006)—a result
that requires the speculative release of rogue catalytic sub-
units to reconcile. Furthermore, Pph3 has known roles in an
evolutionarily conserved phosphatase complex, protein phos-
phatase 4 (PP4), with conserved roles in the DNA damage
response (Gingras et al, 2005; Kim et al, 2007; Mendoza et al,
2007), complicating previous work on Maf1 involving Pph3.
In this study, we provide multiple lines of evidence that the
PP4 complex, with Pph3 as the catalytic subunit, is the major
and direct phosphatase of Maf1. We also identify both the
core and regulatory subunits of PP4 involved in Maf1 depho-
sphorylation. Importantly, PP4/Pph3 is needed for acute
repression in response to diverse stresses, suggesting that
Maf1 and PP4 work together to integrate cell nutrition, stress
and integrity. The work was initiated by employing a Maf1–
Pol III fusion protein, which has proven useful in character-
izing functional PP4 components for this process, and which
may also be useful for revealing and characterizing other
components involved in Pol III repression.
Results
A Maf1–Rpc160 fusion protein recapitulates
Maf1-dependent Pol III transcriptional repression
As nuclear localization of Maf1 is not sufﬁcient for repression
of Pol III, our initial goal was to determine the factors
required for Maf1-dependent execution of Pol III transcrip-
tional repression in the nucleus. To this end, we created a
genetic tool to screen candidate factors: a fusion protein
involving Maf1 fused to the amino-terminus of the large
subunit of RNA Pol III (Rpc160), which directly binds Maf1
during repression (Boguta et al, 1997; Oﬁcjalska-Pham et al,
2006) (see Introduction). We expected this Maf1–Rpc160
protein to integrate into Pol III in the nucleus (bypassing
nuclear/cytoplasmic shuttling), attenuate Pol III activity and
reduce cell/colony growth (addressed below)—enabling us to
screen for Maf1 interactors that would relieve this repression
and restore growth.
Maf1–Rpc160 contains the entire open reading frame
(ORF) of MAF1, a linker of 10 amino acids (aa), the entire
ORF of RPC160, and a 3 HA tag (Figure 1A). Here, we
utilized the GAL1 promoter, which enables galactose-induci-
ble expression of Maf1–Rpc160. A control construct
expressed tagged Rpc160, lacking Maf1. In galactose-contain-
ing medium, the Maf1–Rpc160 fusion and Rpc160 constructs
expressed proteins of the expected B212kDa and B167kDa,
respectively (Supplementary Figure S1A). Co-immunopreci-
pitation (co-IP) experiments between myc-tagged Rpc82 and
HA-tagged Maf1–Rpc160 fusion or HA-tagged Rpc160 con-
ﬁrmed that the fusion protein incorporates into Pol III,
although at a slightly reduced level compared with Rpc160
(Supplementary Figure S1B). To assess Pol III transcription,
northern blot was performed using probes complementary to
U4 (a Pol II target gene, used as an internal control) and pre-
tRNA
Leu3, a Pol III target. Here, pre-tRNAs are examined to
distinguish new transcription from the existing, highly stable
spliced tRNAs. Notably, with fusion expression, new
tRNA
Leu3 production was dramatically reduced (Figure 1B
and C), showing that the Maf1–Rpc160 protein confers Pol III
transcription repression. We note a reduction in tRNA
Leu3
expression with overexpression of Rpc160 alone (Figure 1B),
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reduction seen following overexpression of the Maf1–
Rpc160 fusion.
We also observed growth inhibition when examining
Maf1–Rpc160 transformants on galactose-containing plates,
as determined by colony size (Figure 1D, left and middle
panels). The effect is dominant, as it was observed in WT
(RPC160
þ) cells. The Maf1–Rpc160 fusion protein is incor-
porated into Pol III complexes competent for transcription in
the nucleus, as it complements rpc160D when loss of the WT
Rpc160 (URA3) vector is enforced with 5-ﬂuoroorotic acid
(FOA) (Figure 1D, right panel), with its weak complementa-
tion due to the partial repression of Rpc160 by fused Maf1.
Thus, the functional consequence of Maf1–Rpc160 expres-
sion is reduced expression of Pol III targets, conferring a slow-
growth phenotype termed the ‘fusion growth defect’.
Two controls are needed to ensure that the fusion
growth defect is meaningful and useful, rather than trivial.
First, a trivial explanation for growth inhibition is the over-
expression of Maf1 moiety, with no need for the fusion to
Rpc160. However, no growth defect was observed when we
used the same plasmid backbone to drive Maf1 alone on
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Figure 1 A Maf1–Rpc160 fusion functionally represses Pol III transcription. (A) Constructs of galactose-inducible Rpc160 or Maf1–Rpc160
fusion. (B) Northern blot showing levels of pre-tRNA
Leu3 and U4 in strains with Maf1–Rpc160 or Rpc160 constructs, under conditions of
repression by glucose (lanes 1–4) or induction by galactose (lanes 5–8). Expression of the Maf1–Rpc160 fusion but not Rpc160 represses pre-
tRNA
Leu3 transcription. (C) Quantiﬁcation of lanes 5–8 of (B) as a ratio of tRNA/U4 band intensity with Rpc160 set to 1. Error bars represent
s.d. (D) Expression of the Maf1–Rpc160 fusion but not Rpc160 confers a growth defect in both RPC160þ and rpc160D cells (right and left half
of each plate, respectively). Cells were grown on plates containing glucose, galactose or galactose þ FOA. Note that FOA only permits growth
of cells lacking PMET25Rpc160 as this vector carries a URA3 marker. Two biological replicates are shown for each strain. See Materials and
methods for more details. (E) The fusion growth defect is dependent on a functional Maf1. Strong, dephosphorylation-resistant missense
mutations—maf1-104 or maf1-124—in the Maf1 portion of the fusion partially suppress the fusion growth defect. (F) Yeast transformed with
plasmids for galactose-inducible Rpc160 (p2266), Maf1–Rpc160 (p2268), maf1-124–Rpc160 (p2424) or maf1-104–Rpc160 (p2425) were grown
in galactose for 4h and RNA was isolated immediately, followed by northern blot. Relative transcription is expressed as a ratio of the pre-
tRNA
Leu3 band to U4 band, with Rpc160 set to 1. Data are from a single replicate.
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transcription is observed, but not sufﬁcient to affect growth
(Supplementary Figure S2). More importantly, Maf1 (when
fused to Rpc160) may simply impair Rpc160 by a nonspeciﬁc
mechanism unrelated to Maf1 phosphorylation state, such as
physical blocking. To test for this, we created missense
mutations in the Maf1 portion of the fusion construct, utiliz-
ing previously characterized maf1 alleles (maf1-104 and
maf1-124) conferring point mutations that resist dephosphor-
ylation (Roberts et al, 2006). Notably, these point mutations
within Maf1–Rpc160 fusion proteins greatly attenuated the
fusion growth defect (Figure 1E) and the Pol III transcrip-
tional repressive ability of the fusion protein (Figure 1F).
These experiments and controls strongly suggest that a func-
tional, dephosphorylated Maf1 is needed for repression in the
fusion context, and support the utility of the Maf1–Rpc160
fusion tool for identifying relevant factors involved in
phosphoregulation.
PP4 mediates the Maf1–Rpc160 fusion growth defect
To understand Maf1 dephosphorylation, the correct phospha-
tase catalytic subunit and correct phosphatase complex must
be ﬁrmly established. To clarify, we deﬁned the composition
and roles of PP2A and PP4 in Maf1 dephosphorylation
(Table I). Consistent with previous studies (Gingras et al,
2005), we found that Pph3 interacts with the PP4-speciﬁc
subunit Psy2, but not the PP2A-speciﬁc subunit Tpd3
(Supplementary Figure S3), conﬁrming that Pph3 is part of
PP4 but not PP2A.
We then used the Maf1–Rpc160 fusion tool to assess which
complex (PP4 or PP2A) and which catalytic subunits help
confer the fusion growth defect. We ﬁrst tested the ‘core’
members of PP4: Pph3 (catalytic), Psy2 (regulatory) and Psy4
(regulatory). Importantly, we found growth largely restored
in cells lacking either Pph3 or Psy2 (Figure 2A), establishing
their involvement. In contrast, the lack of Psy4 had little
effect (only slight growth restoration), whereas growth was
restored in the psy2D psy4D double mutation, suggesting that
Psy4 is less important for Pol III repression than Psy2, an
issue developed further below.
Next, we tested PP2A core members and regulatory sub-
units (Cdc55 or Rts1) (Jiang, 2006). Since Pph21 and Pph22
are redundant, we created a double null in the S288C back-
ground to test in our assays. Notably, neither the pph21D
pph22D double mutant nor tpd3D rescued, and actually
enhanced the growth defect (Figure 2B, left three panels).
Furthermore, mutation in either regulatory subunit of PP2A
retained pronounced growth defects (Figure 2B, right two
panels). As shown previously (Roberts et al, 2006), pph21D
pph22D and tpd3D mutants display clear Maf1 dephosphor-
ylation in response to ND or rapamycin treatment
(Supplementary Figure S4). Taken together, these results
point to PP4/Pph3 involvement in Maf1–Rpc160 repression
of Pol III, and not PP2A/Pph21/Pph22.
Pph3 is required for the acute establishment of Pol III
repression
To further investigate Pph3, we assayed WT and pph3D null
strains for (1) Maf1 dephosphorylation, (2) impact on Pol III
transcription and (3) nuclear translocation. For Maf1 depho-
sphorylation, a plasmid encoding HA-tagged Maf1 (controlled
by its endogenous promoter) was transformed into WT or
pph3D strains. As shown previously, ND or rapamycin
(125nM) for 25min causes Maf1 dephosphorylation, where
higher molecular weight phospho-species collapse to an
apparent single band of B50kDa in western blot analysis
(Oﬁcjalska-Pham et al, 2006; Roberts et al, 2006). This
creates a prominent band of unphosphorylated Maf1 that is
derived both from the dephosphorylation of existing phos-
pho-Maf1, and the translation of new Maf1. To examine only
resident Maf1 as opposed to newly translated Maf1, cells
Table I Core components of yeast protein phosphatase 2A (PP2A)
and protein phosphatase 4 (PP4)
PP2A
a PP4
b
Subunit Type Subunit Type
Pph21 Catalytic Pph3 Catalytic
Pph22 Catalytic
Tpd3 Scaffold Psy2 Scaffold/regulatory
Cdc55 Regulatory Psy4 Scaffold/regulatory
Rts1 Regulatory
aFrom Jiang (2006).
bFrom Cohen et al (2005).
A
Rpc160
Empty vector
Maf1–Rpc160
WT pph3Δ psy2Δ psy2Δ psy4Δ psy4Δ
B
Rpc160
Empty vector
Maf1–Rpc160
WT pph21Δ pph22Δ tpd3Δ cdc55Δ rts1Δ
Figure 2 Maf1–Rpc160 fusion identiﬁes Pph3 and Psy2 as Maf1-dependent repressors of Pol III. (A) WTand various PP4 mutants harbouring
plasmids for empty vector, Rpc160 or Maf1–Rpc160 fusion were grown on plates containing galactose. The fusion growth defect is partially
rescued in PP4 mutant strains pph3D and psy2D (two biological replicates in the bottom two rows of spot dilutions) compared with controls
(top two rows). Little effect on the fusion growth defect is seen in psy4D strain. See Materials and methods for details. (B) The fusion growth
defect remains (cdc55D, rts1D) or is intensiﬁed (tpd3D, pph21Dpph22D) in PP2A mutant strains. Note that rows in (B) for each strain are from
the same plate image.
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not cause either Maf1 dephosphorylation or Pol III repression
during acute repression, see below) prior to altering the
growth medium. We found that Pph3 was required for the
vast majority of the dephosphorylation of Maf1 in response
to acute ND or TOR inhibition, as phosphorylated Maf1
clearly persists in the pph3D strain (Figure 3A). We also
conducted ND without CHX and likewise observed a
strong requirement for Pph3 in Maf1 dephosphorylation
(Supplementary Figure S5). As CHX can also activate Sch9
(Urban et al, 2007), a Maf1 kinase, we concurrently included
a WT control to account for any differences in phosphoryla-
tion due solely to enhanced kinase activity. Importantly,
Maf1 is dephosphorylated in WT cells exposed to ND
or rapamycin (and CHX), suggesting that any activation of
Sch9 by CHX does not affect overall dephosphorylation of
Maf1. Curiously, rapamycin treatment moderately reduces
resident Maf1 levels (Figure 3A), an observation that was
not pursued further.
To assess the role of Pph3 in Pol III repression, we isolated
RNA from WT, pph3D and pph3D cells complemented
with a WT PPH3 plasmid. Northern blot analysis revealed
the pph3D strain defective for Pol III repression in ND
(Figure 3B). Notably, the defect was complemented by a
Pph3 derivative FLAG-tagged at the N-terminus (Figure 3B,
bottom panel).
Furthermore, pph3D mutants show a defect/delay in the
translocation/accumulation of Maf1 in the nucleus compared
with WT (Figure 3C–E). After 30min of ND, Maf1 is largely
nuclear in WT, but largely cytoplasmic in pph3D strains
(Figure 3C–E). After 6h, the Maf1 localization proﬁles appear
similar in WT and pph3D, consistent with a role for Pph3 in
acute, but not prolonged repression of Pol III transcription.
We note that independence from the phosphatase during
prolonged repression is predicted, as the translation and
accumulation of new Maf1 (unphosphorylated) occurs during
prolonged ND (Oﬁcjalska-Pham et al, 2006; Roberts et al,
2006).
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Figure 3 Pph3 mediates Pol III repression. (A) Western blot of WT and pph3D yeast treated with ND or rapamycin (Rap). ND and Rap
treatment cause dephosphorylation of Maf1 in WT but not pph3D mutant strain. (B) Northern blot showing repression of pre-tRNA
Leu3
transcription in WTstrain (top panel) in response to ND. Repression is attenuated in pph3D strain (third panel) and repression is restored by
complementing with Pph3 on a plasmid (bottom panel). Lack of Pol III repression in maf1D strain is shown for comparison (second panel).
Two biological replicates are shown. (C, D) Nuclear localization of Maf1–HA in response to ND in (C) WTand (D) pph3D. Maf1 is stained red
while nuclear DNA is stained blue (DAPI). Localization of Maf1 to the nucleus is delayed in pph3D compared with WT. (E) Distribution of Maf1
localization in WT and pph3D strains at T¼0 (left panel; n¼230 for WT, n¼150 for pph3D), T¼30min (middle panel; n¼470 for WT,
n¼986 for pph3D) and T¼6h (right panel; n¼239 for WT, n¼341 for pph3D). Signiﬁcance values calculated as difference between nuclear
(NbC, N4C) and cytoplasmic (C4N, CEN) Maf1 in WTand pph3D using Fisher’s exact test. (F) ChIP of Maf1 in WTor pph3D cells at T¼0o r
25min ND treatment. ChIP values are expressed as enrichment over a control locus, the Tra1 gene.
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genes
To determine whether Pph3 plays a role in recruitment of
Maf1 to Pol III, we performed ChIP of Maf1 in WTand pph3D
cells both before and following 30min ND (Figure 3F). First,
we found that basal Maf1 ChIP levels are lower in pph3D cells
compared with WT. Second, recruitment of Maf1 during ND
is greatly attenuated in pph3D cells compared with WTcells.
Taken together, these results are consistent with a model for
PP4 in maintaining a basal level of Maf1 at Pol III loci, as well
as enabling enhanced recruitment of Maf1 in response to
stress.
Maf1 dephosphorylation and Pol III repression requires
particular subunits of PP4, but not PP2A
Above, the Maf1–Rpc160 fusion growth defect was greatly
attenuated in cells lacking Pph3 or Psy2, but not Psy4. In
keeping with this, we ﬁnd Psy2 required for Maf1 depho-
sphorylation, but not Psy4 (Figure 4A). Notably, Pph3 and
Psy2 still physically interact the psy4D strain (Figure 4B).
Pph3 likely functions through PP4, as Psy2 is similarly
required for Pol III transcriptional repression in response to
ND, rapamycin or methyl methanesulphonate (MMS)
(Figure 4C).
To further investigate PP4, we used the fusion construct to
screen other proteins that regulate PP4. The yeast protein
tyrosyl phosphatase activators Rrd1 and Rrd2 activate PP2A-
like phosphatases (Van Hoof et al, 2005). Rrd1 activates
Pph3, Sit4 and Ppg1, while Rrd2 activates Pph21/22.
Consistent with a role for Rrd1 in activating PP4, rrd1D
mutants largely rescue the fusion growth defect (Figure 5A)
and are defective for full Maf1 dephosphorylation in ND and
rapamycin treatment (Figure 5B). In contrast, rrd2D mutants
are not rescued (similar to pph21D pph22D or tpd3D mutants)
and display full Maf1 dephosphorylation in ND or rapamycin
(Figure 5). Tip41 is a TOR signalling pathway member that
physically interacts with PP2A family phosphatases, includ-
ing Pph3, Pph21/22 and Sit4 (Jacinto et al, 2001; Santhanam
et al, 2004; Gingras et al, 2005). Upon inhibition of TOR,
Tip41 binds and activates these phosphatases (Jacinto et al,
2001; Gingras et al, 2005). We ﬁnd that tip41D mutants rescue
the fusion growth defect (Figure 5A) and are defective in full
dephosphorylation of Maf1 (Figure 5B), consistent with the
results of the fusion growth assay. Taken together, strains
with mutations in PP2A components enhance the fusion
growth defect and retain rapid Maf1 dephosphorylation,
whereas strains with PP4 mutations suppress the fusion growth
defect and are defective for full Maf1 dephosphorylation—
displaying the utility of the Maf1–Rpc160 fusion for revealing
involved factors.
Pph3 interacts with Maf1
We next tested whether Pph3 interacts with Maf1 via co-IP in
extracts. As effective polyclonal antibodies are not available,
we cloned a FLAG-tagged Pph3 derivative under the control
of the MET25 promoter (enabling moderate overexpression)
and co-expressed with HA-tagged Maf1. We note that this
moderate Pph3 overexpression does not cause Maf1 depho-
sphorylation or Pol III repression, consistent with its incor-
poration (see Supplementary Figure S3) and regulation by
other PP4 components. We examined interaction by co-IP in
unstressed cells as well as cells stressed with MMS for 30min
to activate the phosphatase. In both stressed and unstressed
cells, we detect a speciﬁc interaction of Maf1 with Pph3,
enriched well above background (Figure 6A and B), but
representing only a small fraction of total, consistent with
its other roles and substrates. A similar level of association
was detected in crosslinked (1% formaldehyde, to capture the
enzyme–substrate complex; Figure 6A and B) and uncros-
slinked extracts (Supplementary Figure S6).
PP4 is localized in the nucleus
During DNA damage recovery, PP4 dephosphorylates nuclear
Rad53 and gH2AX (Keogh et al, 2006; O’Neill et al, 2007).
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Figure 4 PP4 complex members play a role in steps of Pol III
repression. (A) Western blot of WT, psy2D and psy4D yeast treated
with ND or rapamycin (Rap). Maf1 is dephosphorylated in WTand
the psy4D mutant, but not in the psy2D mutant in response to ND
and Rap treatment. (B) Co-IP of tagged Pph3–FLAG and Psy2–HA in
psy4D mutant strain, revealed by western blot. Psy2 and Pph3 can
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Maf1 is constitutively nuclear but still requires dephosphor-
ylation to repress Pol III (Towpik et al, 2008). Thus, the Maf1
phosphatase should be present in the nucleus. To determine
the location of PP4, we obtained GFP-tagged Pph3 or Psy2
strains. Psy2–GFP strains show growth similar to WT in
camptothecin, which activates PP4-requiring steps in the
DNA damage response, whereas Pph3–GFP strains show
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Figure 5 Pol III repression requires PP4 accessory factors Rrd1 and Tip41. (A) The fusion growth defect is rescued in rrd1D and tip41D
mutants, but not rrd2D. See Materials and methods for details. (B) Western blot showing PP4-associated factors Tip41 and Rrd1 are required for
dephosphorylation of Maf1 during ND or exposure to rapamycin, whereas PP2A-associated Rrd2 is not required, correlating to the fusion
growth data in (A).
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ing impairment due to GFP fusion. Accordingly, we focussed
on Psy2–GFP, which shows strong nuclear localization
(Figure 6C), consistent with previous results (Huh et al,
2003). This supports PP4 action on Maf1 in the nucleus,
with the accumulation of Maf1 in the nucleus during stress
due to the inability to shuttle dephosphorylated Maf1 out of
the nucleus by Msn5 (Towpik et al, 2008).
To further address Pph3 action in the nucleus, we utilized a
Maf1 mutant derivative, Maf1
7A (or maf1-7A), in which
seven serines known to be phosphorylated in Maf1 are
replaced with alanine (Huber et al, 2009). In nutrient replete
conditions, this derivative localizes largely to the nucleus,
shows increased (but not complete) association with Pol III
and confers slight tRNA repression while remaining highly
responsive to Pol III repression during rapamycin treatment
(Huber et al, 2009). Therefore, maf1-7A possesses a weak
gain-of-function for repression, yet retains full responsive-
ness. We ﬁnd maf1-7A–Rpc160 fusion more potent at growth
inhibition than Maf1–Rpc160, consistent with dephosphory-
lation promoting repression (Supplementary Figure S8A
and B). We also observe partial growth suppression of the
maf1-7A–Rpc160 by pph3D (Supplementary Figure S8A), and
attenuated tRNA
Leu3 repression (Supplementary Figure S8C),
consistent with the possible presence of additional phospho-
serine residues on maf1-7A that require Pph3 action for full
repression.
We tested for association of Pph3 with a set of Pol III target
genes by ChIP in both nutrient replete and deprivation
conditions, and did not observe signiﬁcant association
(Supplementary Figure S9), suggesting that PP4 action on
Maf1 occurs in the nucleoplasm, though the lack of positive
controls (established PP4-associated loci) prevents deﬁnitive
assessment.
PP4 dephosphorylates Maf1 in vitro
To test whether PP4 can directly dephosphorylate Maf1, we
reconstituted Maf1 dephosphorylation by PP4 in vitro from
partially puriﬁed components. PP4 was isolated as described
previously, by forming IgG-bound complexes from a Pph3–
TAP strain, which provides highly puriﬁed material (O’Neill
et al, 2007). Pph3–TAP tagged proteins bind stably to the
other components of PP4 (e.g., Pph3, Psy2 and Psy4) and
confer phosphatase activity (O’Neill et al, 2007), and yielded
the same spectrum of proteins provided previously. The
substrate—phosphorylated Maf1—was isolated by puriﬁca-
tion from a pph3D strain, using a 10 His tag and a high-
stringency procedure (see Materials and methods). To cali-
brate PP4 activity on Maf1, we isolated phosphorylated
Rad53, a known native substrate of PP4 (O’Neill et al,
2007). Indeed, tests for a new enzyme substrate are often
accompanied by assays on a known substrate to determine
relative turnover numbers. We also used l phosphatase to
provide a positive control for a highly active (though non-
speciﬁc) phosphatase enzyme. We note that reconstitution
biochemistry typically utilizes in vitro incubation times that
are much longer than the in vivo kinetics of a reaction, for
obvious reasons.
In our in vitro reconstitution, we observed clear depho-
sphorylation of the known substrate, Rad53, by Pph3–TAP at
2 and 8h (Figure 6D, bottom panels). By quantifying the
change in Rad53 mobility, Pph3–TAP has 22.2% (±0.7) of
the activity of l phosphatase at 2h, and 34.8% (±3.1) of the
activity at 8h (when comparing the change in the bottom
band as a percentage of total Rad53 signal per lane; see
Materials and methods). For Maf1, dephosphorylation is not
easily seen or quantiﬁed at 2h, due to the modest separation
of the bands (Figure 6D, top panels). However, at 8h, depho-
sphorylation is clearly observed, representing 43.0% (±4.1)
of the activity of l phosphatase. Furthermore, the activity
observed on Maf1 is similar to the known substrate Rad53.
We note that determination of dephosphorylation kinetics in
certain preparations of Maf1 was prevented by variable levels of
a contaminating protease. Taken together, the PP4 complex
(containing Pph3) dephosphorylates Maf1 in vitro at rates similar
to Rad53, consistent with its identity as an authentic substrate.
PP4 is an integrator of multiple signals for Maf1
dephosphorylation
PP4 might be one of many Maf1 phosphatases with relatively
equal impact, or instead be responsible for the vast majority
of Maf1 dephosphorylation during the acute response to
known stresses—essentially functioning as a co-integrator
with Maf1. To address this, and to extend beyond our
examination of ND (lacking glucose) or rapamycin treatment,
extracts were prepared from WT and pph3D cells stressed
with one of multiple conditions/agents: the DNA-damaging
agent MMS, CHX, chlorpromazine (CPZ), dithiothreitol
(DTT) or phosphate deprivation—all of which have been
associated with Pol III repression (except phosphorus depri-
vation) (Willis et al, 2004). Phosphorus deprivation was
included as it causes nuclear accumulation of tRNAs, similar
to DNA damage (Ghavidel et al, 2007; Hurto et al, 2007),
although whether it causes Pol III transcription repression or
Maf1 dephosphorylation has not been tested. Notably, we
ﬁnd that DNA damage or replication fork stress (with MMS),
endoplasmic reticulum stress (with DTT), cell wall stress
(with CPZ) and phosphorus deprivation are clearly Pph3-
dependent stresses (Figure 7A and B). With CHX treatment,
dephosphorylation of Maf1 begins between 30 and 60min,
and this dephosphorylation is Pph3 dependent (Figure 7C).
These ﬁndings demonstrate that PP4/Pph3 phosphatase is
involved in the integration of multiple nutrient and stress
signals to affect the dephosphorylation of Maf1.
Discussion
Maf1 is a conserved and central regulator of Pol III repression
in all organisms tested, making its mode of regulation an
issue of high interest. Here, the rapid repression of Pol III is
likely important for conserving protein synthesis resources
when unfavourable conditions are encountered. The rapid
establishment of Pol III repression is correlated with the
extent of Maf1 dephosphorylation in all conditions tested,
and mutations that impair dephosphorylation impair repres-
sion, making the dephosphorylation mechanism a key feature
of Maf1 regulation. Thus, it is critical to identify the correct
phosphatase complex, the precise catalytic subunit, and
which attendant subunits are needed for Maf1 dephosphor-
ylation. Here, we establish PP4 as the major Maf1 phospha-
tase complex for acute Pol III repression, identify Pph3 as the
involved catalytic subunit, identify the PP4 core and regula-
tory/interacting proteins involved in Maf1 dephosphoryla-
tion, show physical PP4 interaction with Maf1, and
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providing evidence that the effect is direct (Figure 7D).
Our identiﬁcation of PP4 as the major Maf1 phosphatase
was enabled by a fusion protein, Maf1–Rpc160, which
allowed us to test candidate PP2A-related complexes and
components, and provided clear evidence for participation
by certain PP4 members, but not PP2A. This was conﬁrmed
by extensive additional experiments on PP4 and PP2A, and
their impact on Maf1 and Pol III repression in the natural
(nonfused) context. Prior studies have shown that certain
phosphorylation sites on Maf1 are involved in nuclear–
cytoplasmic shuttling, raising the possibility that yeast simply
use Maf1 phospho-dynamics to control the shuttling aspect of
Maf1 regulation, but not the execution of Pol III repression in
the nucleus. However, studies in yeast have shown that
nuclear accumulation of Maf1 is insufﬁcient to repress Pol
III (Moir et al, 2006; Towpik et al, 2008). In addition,
vertebrate Maf1, although under phosphoregulation, is con-
stitutively nuclear (Kantidakis et al, 2010). These results
suggest that Maf1 dephosphorylation is critical for repres-
sion, but is not used to control nuclear localization in all
species. We note that although overexpression of Maf1
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Figure 7 Pph3 is required for dephosphorylation of Maf1 in multiple stress conditions. (A–C) Involvement of Pph3 in Maf1 dephosphorylation
in (A) MMS, CPZ, DTT, (B) phosphorus deprivation (–P) and (C) extended CHX treatment. See Materials and methods for details on growth
conditions. (D) Model for PP4-dependent regulation of Maf1 action in repression of Pol III. In favourable growth conditions (left panel), activity
of Maf1 kinases predominates over activity of PP4, inhibiting Maf1–Pol III interaction and allowing Pol III to remain active. Phosphorylated
Maf1 is exported from the nucleus in an Msn5-dependent manner in S288C background yeast. Maf1 is shuttled into the nucleus due to nuclear
localization sequences. Hyperphosphorylated Maf1 is represented with multiple P’s, while hypophosphorylated Maf1 is represented by Maf1
lacking P’s. Darkly coloured Maf1 illustrates the predominating species of Maf1: hyperphosphorylated form in favourable growth (left), and
hypophosphorylated form in unfavourable growth (right). In conditions where Maf1 is predominately phosphorylated (left panel), the rate of
export by Msn5 is high, leading to mostly cytoplasmic localization. Lightly coloured Maf1 represents a small or diminishing pool of Maf1, due
to action by kinases in favourable growth (left panel) or by the PP4 phosphatase in unfavourable growth (right panel). In unfavourable growth
conditions (right panel), activity of PP4 phosphatase predominates over kinase activity, producing hypophosphorylated Maf1, which binds
tightly to Pol III and inhibits its activity. Double arrows between Rrd1, Tip41 and components of PP4 represent physical interaction based on
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served, suggesting that cells must cross a threshold of very
low tRNA abundance before conferring a clear growth defect.
Our results add to our understanding of Maf1 localization
during repression of Pol III. Although initial models suggested
that Maf1 is dephosphorylated in the cytoplasm prior to
nuclear localization, the mechanism is likely more complex.
Maf1 contains two nuclear localization signals, one closer to
the amino-terminus (NtNLS) and one closer to the carboxy-
terminus (CtNLS). The NtNLS has been shown to be adjacent
to serines phosphorylated by PKA and Sch9, and this NtNLS
is rendered nonfunctional in the phosphorylated state (Moir
et al, 2006; Huber et al, 2009; Lee et al, 2009). However,
based on studies of the msn5D null, lacking the Maf1
exportin, Maf1 can be phosphorylated and dephosphorylated
within the nucleus (Towpik et al, 2008). Consistent with this,
we ﬁnd an essential subunit of PP4 complex, Psy2, located in
the nucleus, supporting Maf1 dephosphorylation in the
nucleus. Importantly, even in maf1 mutants with inactivated
NtNLS (by either deletion of the NLS signal or phosphomi-
metic 6SE mutation), nuclear accumulation can occur readily
upon stress (Moir et al, 2006). In addition, since the CtNLS is
not adjacent to known or predicted phosphorylation sites, it
is possible that the CtNLS is constitutively active in Maf1
nuclear translocation, regardless of Maf1 phosphorylation
state. One possible model involves constitutive, low-level
translocation of phosphorylated Maf1 to the nucleus during
favourable growth conditions, countered by constitutive
export by Msn5. In unfavourable conditions, Maf1 is depho-
sphorylated in the nucleus, preventing its export by
Msn5, thus leading to nuclear accumulation (Figure 7D).
Importantly, in mutants where Maf1 is constitutively nuclear
(e.g., msn5D, maf1-6SA, maf1-7A), Pol III is not constitu-
tively repressed, and maf1-7A mutants respond robustly to
rapamycin (Huber et al, 2009), suggesting an additional
required step beyond nuclear localization/retention, such as
dephosphorylation at additional positions to confer Pol III
repression. Although PP4 is clearly involved in nuclear
localization of Maf1, it is also likely involved in this addi-
tional required step, since the fusion growth defect of maf1-
7A–Rpc160 is partially rescued in pph3D mutants, and Pph3
is required for full Pol III repression by maf1-7A mutant yeast
in ND treatment (Supplementary Figure S8).
Whereas multiple kinases act on Maf1, PP4 appears to
mediate the majority of Maf1 dephosphorylation during the
acute response to rapamycin, DNA damage, CPZ, CHX and
ND—and is needed for the acute establishment of Pol III
repression. (We note, however, that long-term Pol III repres-
sion appears to be independent of PP4, which likely involves
the de novo translation and accumulation of unphosphory-
lated Maf1 over time.) Taken together, one straightforward
interpretation of our data is that PP4 functions with Maf1 as a
co-integrator of environmental conditions. To further test
this, the interplay between the various Maf1 kinases and
PP4 in favourable versus unfavourable growth conditions
should be investigated. Speciﬁcally, it is not clear whether
PP4 constitutively dephosphorylates Maf1—with the Maf1
kinases attenuated during stress—or whether PP4 activity
towards Maf1 is increased in poor growth conditions. These
models are not exclusive, and both could be involved. If PP4
is relatively constitutive, Maf1 activity could be kept in
balance by kinase activation/deactivation in response to
growth conditions, where poor growth conditions would
lead to kinase inhibition, and PP4 removing the phosphory-
lated pool. Indeed, TORC1 activity is inhibited by ND and
rapamycin, consistent with this model. However, in our view,
some regulation of PP4 activity during stress seems likely, as
a single type of stress (like DNA damage) causes Pol III
repression even though the Maf1 kinases that assess nutrient
availability remain active. Furthermore, there are known
roles for TOR and Tap42 in regulating phosphatase activities.
Our data does not support a major change in PP4–Maf1
interaction during stress, so if PP4 activation occurs, it likely
involves improving its catalytic turnover. Therefore, under-
standing PP4 regulation and substrate selection is an impor-
tant next step.
PP4 participates in the DNA damage response in multiple
species, including yeast, human, Caenorhabditis elegans and
Drosophila (Cohen et al, 2005; Gingras et al, 2005; Kim et al,
2007). This involves dephosphorylation of Rad53, which
helps overcome G2/M arrest (O’Neill et al, 2007). In
Dictyostelium discoideum, the PP4 complex is activated in
response to starvation conditions to enable differentiation
into fruiting bodies (Mendoza et al, 2005, 2007). In addition
to its role in the DNA damage response, C. elegans smk-1
(homologue of Psy2) is required for the response to oxidative
and innate immune stress required for long-lived worms
(Wolff et al, 2006). Given the role for PP4 in the environ-
mental stress response of higher organisms, a role for PP4
in Maf1 dephosphorylation in higher organisms should be
explored.
Our ﬁndings also inform the compositional requirements
of PP4 for dephosphorylation of Maf1. Here, PP4 ‘core’
components Pph3 and Psy2 are required for dephosphoryla-
tion of Maf1, while Psy4 is not. Notably, Psy4 is required for
dephosphorylation of gH2AX but not Rad53, while Psy2 is
required for all known substrates (Keogh et al, 2006; O’Neill
et al, 2007). Less is known regarding the use of ‘noncore’ PP4
subunits in substrate selection, and here we identify Tip41
and Rrd1 as important for full Maf1 dephosphorylation. Tip41
acts in concert with PP4 in DNA damage (Gingras et al, 2005)
and activates Sit4 and PP2A catalytic subunits towards Gln3
(Jacinto et al, 2001) and Msn2 (Santhanam et al, 2004),
respectively. Rrd1 and Rrd2 are yeast homologues of
human phosphotyrosyl phosphatase activator (PTPA); Rrd1
activates several PP2A family phosphatases in vitro, but
selectively binds Pph3 (and not Pph21/22) in vivo (Van
Hoof et al, 2005). PTPA has prolyl isomerase activity, which
activates PP2A catalytic subunits (Jordens et al, 2006). The
proline residue involved in human PP2AC is Pro190, which is
conserved in Pph3, suggesting a conserved mechanism of
activation.
Our data does not support a role for PP2A as the main
phosphatase of Maf1 (Oﬁcjalska-Pham et al, 2006), or as a
phosphatase needed for acute repression. In both tpd3D
(scaffold) and pph21D pph22D (alternative catalytic) double
mutants, Maf1 is completely dephosphorylated under stress
conditions and with rapid kinetics, and the fusion growth
defect is not rescued in these genetic backgrounds (Figure 2;
Supplementary Figure S4). This is also true in rrd2D mutants,
which lack a PP2A-speciﬁc activator (Figure 5). In fact, in
PP2A mutants, we observe an enhanced fusion growth
defect, suggesting that disruption of PP2A causes cellular
stress, which elicits, rather than compromises, Pol III
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genotypes defective for Maf1 dephosphorylation involved
combinations of pph21 or pph22 along with pph3D, which
at the time was erroneously considered a redundant PP2A
catalytic subunit; pph3D was never examined in isolation,
which we conﬁrm here as exclusively a subunit of PP4.
Although Pph3/PP4 is identiﬁed as the main and required
Maf1 phosphatase, the slight Maf1 dephosphorylation ob-
served during ND in pph3D cells (Figure 3A) leaves open the
possibility for alternative minor phosphatases for Maf1 de-
phosphorylation.
Recently, the co-structure of Maf1 with yeast Pol III was
solved (Vannini et al, 2010), and showed Maf1 binding the
clamp domain of Rpc160 (aa 1–245). Therefore, Maf1 fused
to the amino-terminus of Rpc160 is an ideal position to poise
the complex for repression. Binding of Maf1 causes a shift in
the position of the C34 subunit that prevents Brf1 binding,
effectively inhibiting TFIIIB–Pol III interactions. Other struc-
tural studies of Maf1 protein have shown that the phosphory-
lated form of Maf1 is correlated with absence of interaction
between its amino-terminal A domain and its carboxyl-term-
inal BC domain, while dephosphorylation is correlated with
their interaction (Gajda et al, 2010). Thus, dephosphorylation
may create a more compact Maf1 that binds in the pocket
between C34 and C82 in the Pol III complex. These structural
studies may help us understand the utility of our Maf1–
Rpc160 fusion tool. First, the Maf1–Rpc160 fusion growth
defect can be intensiﬁed to complete growth arrest by addi-
tion of 10nM rapamycin (unpublished observations), or
instead attenuated by deletion of PP4 phosphatase compo-
nents. We suggest that in unfavourable growth conditions,
Maf1 in the fusion context becomes fully dephosphorylated,
enhancing its regulated interaction with the Pol III complex,
further inhibiting Pol III interaction with TFIIIB and further
decreasing transcription. Accordingly, in PP4 mutants, Maf1
is phosphorylated, eliminating A and BC domain interaction,
allowing Brf1 association and normal Pol III activity and
growth. We envision ourselves and others utilizing the
Maf1–Rpc160 fusion to further investigate factors involved
in Pol III repression.
Materials and methods
Growth conditions
We used standard culture methods. See Supplementary Table SI for
strains. For monitoring phosphorylation status of Maf1, we grew
initial cultures to OD600 B0.5–0.7 (T¼0), after which we applied a
stress treatment. We added CHX (5mg/ml) to cultures 5min prior to
application of stress treatment, unless otherwise indicated. Stress
treatments are as follows: rapamycin (125nM; Sigma); methyl
methanesulphonate (0.13%; Sigma); CPZ (250mM; Sigma); ND
(0.15  synthetic complete (SC), no glucose); phosphorus depriva-
tion (SC made without nitrogen base mix (Difco), re-adding
ammonium sulphate, biotin, calcium pantothenate, inositol, all
trace elements, magnesium sulphate, magnesium chloride, sodium
chloride and calcium chloride but not potassium phosphate)
(Sherman, 2002); DTT (5mM). We harvested a portion of the
culture before applying stress (T¼0) and after the speciﬁed time of
stress treatment. At harvest, we crosslinked cells for 15–30min in
1% formaldehyde at room temperature (RT; 231C), and washed
three times with TBS. For co-IP, we grew cultures to OD600 B1 and
did not crosslink them, unless otherwise indicated. For northern
blot, we grew cells to OD600 B0.5, then applied treatment. For all
experiments, we froze cells in liquid nitrogen, or prepared extracts
immediately. For fusion growth assay spot dilutions, we prepared
overnight cultures in SC dropout plus glucose and spotted to plates
with glucose, galactose and/or FOA. We incubated plates at RT
(B231C) for 4–6 days, until the size of control colonies (i.e., those
containing plasmid p2266 or p518) was equivalent between strains.
The fusion growth defect was then assayed in strains harbouring
the Maf1–Rpc160 fusion (plasmid p2268).
Extract preparation, co-IP and western blot
For Maf1 phosphorylation western blot and crosslinked co-IP, we
broke cells with 1mm glass beads in ChIP lysis buffer (Roberts et al,
2006), sonicated six times with microprobe for 30s on highest
setting and clariﬁed by centrifugation. For noncrosslinked co-IP, we
prepared extracts in a similar manner, except using lysis buffer
(50mM Tris–HCl pH 7.5, 200mM NaCl, 0.1% Triton, 1mM EDTA,
10% glycerol, 0.1mM DTT and protease inhibitors) and no
sonication. We measured protein concentration with Bio-Rad assay
and loaded equal protein amounts (usually 30mg per lane). For co-
IP, we incubated 40ml Dynabeads (Invitrogen; preincubated with
BSA plus 2mg anti-HA [12CA5] antibody) or FLAG-agarose beads
(Sigma; prewashed with lysis buffer) with 1mg of extract for 4–6h
at 41C, eluted with 2  SDS sample buffer or FLAG peptide (Sigma)
and used half of the eluate for western blot. For Maf1 phosphoryla-
tion western blot, we used 10% gels with a 1:125 bis–acrylamide
ratio. We performed western blot with anti-HA antibody (either
12CA5 or Abcam 9110), anti-FLAG (Sigma) or anti-Myc (9E10).
Northern blot
We isolated RNA and performed northern blot as described (Roberts
et al, 2006), using 20mg per lane and overnight hybridization with
end-labelled probes. Blots were exposed to phosphoimager screen
(GE Healthcare) for 24h, scanned with Typhoon (GE Healthcare),
and the images were quantiﬁed using ImageQuant or ImageQuant
TL (IQTL; GE Healthcare).
Fluorescence microscopy
We performed immunoﬂuorescence for Maf1 as described (Roberts
et al, 2006). We treated live Psy2–GFP yeast cells with Hoechst to
stain nuclei and visualized with confocal microscope.
Chromatin immunoprecipitation
ChIP assay was performed as described (Roberts et al, 2006; Oler
et al, 2010). In all, 1mg of sonicate was incubated with mouse or
rabbit Dynabeads (Invitrogen) and 5mg of anti-myc (9E11; Abcam
ab56) or anti-HA (Abcam 9110) antibody overnight. Beads were
washed and eluted with TES (10mM Tris, pH 8.0, 1mM EDTA, 1%
SDS). Eluate was subjected to qPCR with serially diluted yeast
genomic DNA used for primer standard curves to calculate starting
copy numbers using iCycler software (Bio-Rad). Primers used for
qPCR were described previously (Roberts et al, 2006; Graczyk et al,
2011).
In vitro dephosphorylation assay
We incubated autophosphorylated yeast 6 His–Rad53 (puriﬁed
from Escherichia coli) or phosphorylated yeast 10 His-3 HA–
Maf1 (overexpressed in pph3D strain) with Pph3–TAP complexes or
l phosphatase for 2 or 8h. See Supplementary data for more details.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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